| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce75d2649d80adfeb7ac2bbb1a3a5989
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3521 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| filingDate |
1993-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c976b0e14e1e6bfd67932ce499509f0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc113134abd22eeed3bd6098d721b200
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d422095bf35e4936ceec9dfff8b48c71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d7accfd75caa3839de0539e2bdd839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_227e625de5f3fd13019a57d115081b84 |
| publicationDate |
1994-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H06296492-A |
| titleOfInvention |
Anti-hepatitis C virus oligonucleotide |
| abstract |
(57) [Summary] [Object] To provide a therapeutic agent for hepatitis C having an antisense nucleic acid sequence against hepatitis C virus (HCV). [PROBLEMS] To prepare an antisense compound having an extremely high activity of inhibiting HCV virus replication, which comprises an antisense nucleic acid targeting a specific nucleic acid sequence in the 5'untranslated region of hepatitis C virus gene. To obtain an effective therapeutic agent for hepatitis C. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008283975-A |
| priorityDate |
1993-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |